Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1381 AL 1395

Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation

Lee SY, Jeong S, Kim J, Chung SK.

Stem Cell Res. 2018 Jul;30:145-149. doi: 10.1016/j.scr.2018.06.002. Epub 2018 Jun 9.

Consensus for the measurement of the camptocormia angle in the standing patient

Margraf NG, Wolke R, Granert O, Berardelli A, Bloem BR, Djaldetti R, Espay AJ, Fasano A, Furusawa Y, Giladi N, Hallett M, Jankovic J, Murata M, Tinazzi M, Volkmann J, Berg D, Deuschl G.

Parkinsonism Relat Disord. 2018 Jul;52:1-5. doi: 10.1016/j.parkreldis.2018.06.013. Epub 2018 Jun 8.

Quality of life and Parkinson's disease: Philippine translation and validation of the Parkinson's disease questionnaire

Suratos CTR, Saranza GRM, Sumalapao DEP, Jamora RDG.

J Clin Neurosci. 2018 Aug;54:156-160. doi: 10.1016/j.jocn.2018.06.013. Epub 2018 Jun 12.

NMDA antagonists for treating the non-motor symptoms in Parkinson's disease

Vanle B, Olcott W, Jimenez J, Bashmi L, Danovitch I, IsHak WW.

Transl Psychiatry. 2018 Jun 15;8(1):117. doi: 10.1038/s41398-018-0162-2.

Comparable indicators of therapeutic misconception between epilepsy or Parkinson's disease patients between those with clinical trial experience and trial non-participants

Reijula E, Halkoaho A, Pietilä AM, Selander T, Martikainen K, Kälviäinen R, Keränen T.

Seizure. 2018 Aug;60:61-67. doi: 10.1016/j.seizure.2018.06.006. Epub 2018 Jun 9.

Metabolic syndrome contributes to cognitive impairment in patients with Parkinson's disease

Peng Z, Dong S, Tao Y, Huo Y, Zhou Z, Huang W, Qu H, Liu J, Chen Y, Xu Z, Wang Y, Zhou H.

Parkinsonism Relat Disord. 2018 Oct;55:68-74. doi: 10.1016/j.parkreldis.2018.05.013. Epub 2018 May 16.

Adenosine role in brain functions: Pathophysiological influence on Parkinson's disease and other brain disorders

Soliman AM, Fathalla AM, Moustafa AA.

Pharmacol Rep. 2018 Aug;70(4):661-667. doi: 10.1016/j.pharep.2018.02.003. Epub 2018 Feb 3.

Transdermal rotigotine patch in Parkinson's disease with a history of intestinal operation

Ogawa T, Oyama G, Hattori N.

BMJ Case Rep. 2018 Jun 15;2018:bcr2017223722. doi: 10.1136/bcr-2017-223722.

[Diagnosis and treatment of motor phenomena in schizophrenia spectrum disorders]

Walther S, Stegmayer K.

Ther Umsch. 2018 Jun;75(1):31-36. doi: 10.1024/0040-5930/a000963.

Biallelic Parkin (PARK2) mutations can cause a bvFTD phenotype without clinically relevant parkinsonism

Zimmermann M, Wilke C, Schulte C, Hoffmann J, Klopfer J, Reimold M, Brockmann K, Synofzik M.

Parkinsonism Relat Disord. 2018 Oct;55:145-147. doi: 10.1016/j.parkreldis.2018.06.006. Epub 2018 Jun 6.

Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study

Borm CDJM, Krismer F, Wenning GK, Seppi K, Poewe W, Pellecchia MT, Barone P, Johnsen EL, Østergaard K, Gurevich T, Djaldetti R, Sambati L, Cortelli P, Petrović I, Kostić VS, Brožová H, Růžička E, Marti MJ, Tolosa E, Canesi M, Post B, Nonnekes J, Bloem BR; European MSA Study Group (EMSA-SG).

Parkinsonism Relat Disord. 2018 Nov;56:33-40. doi: 10.1016/j.parkreldis.2018.06.015. Epub 2018 Jun 8.

Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders

Verma MK, Goel R, Krishnadas N, Nemmani KVS.

Expert Opin Ther Targets. 2018 Jul;22(7):615-628. doi: 10.1080/14728222.2018.1487952. Epub 2018 Jun 22.

Frequency of speech disruptions in Parkinson's Disease and developmental stuttering: A comparison among speech tasks

Juste FS, Sassi FC, Costa JB, de Andrade CRF.

PLoS One. 2018 Jun 18;13(6):e0199054. doi: 10.1371/journal.pone.0199054. eCollection 2018.

Challenges in Passive Immunization Strategies to Treat Parkinson Disease

Manfredsson FP, Tansey MG, Golde TE.

JAMA Neurol. 2018 Oct 1;75(10):1180-1181. doi: 10.1001/jamaneurol.2018.0346.

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial

Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG.

JAMA Neurol. 2018 Oct 1;75(10):1206-1214. doi: 10.1001/jamaneurol.2018.1487.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias